Carrara shareholders approve PreveCeutical RTO

2017-05-19 16:58 ET - News Release

Mr. Robert Coltura reports
Carrara Announces Results of Annual General and Special Meeting
Carrara Exploration Corp. has released the results of its annual general and special meeting, which was held in Vancouver on May 19, 2017, at 10 a.m. for the purpose of approving the reverse takeover of the company by PreveCeutical Medical Inc., approving the consolidation of the currently issued and outstanding common shares in the capital of the company, approving the company's stock option plan, as well as the annual business of receiving financial statements and the auditor's report thereon, appointing auditor, fixing the number of directors, and electing directors.

A total of 8,790,500 common shares (73.33 per cent) were represented at the meeting, and the company's shareholders voted unanimously in favour of all resolutions, including the transaction and the consolidation. Detailed voting results for the meeting are summarized in the attached table.